The DOI matches its Crossref record; 289 of the 289 references it cites were found in a registry or an index.
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
Enomoto, A., Kimura, H., Chairoungdua, A., Shigeta, Y., Jutabha, P., Ho Cha, S., Hosoyamada, M., Takeda, M., Sekine, T., Igarashi, T., et al. (2002) · Nature · doi:10.1038/nature742 · Cited by 1,535
Clinical pharmacokinetics of metformin
Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
Kim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M., & Wilkinson, G. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1269 · Cited by 1,054
Self-citationHagenbuch, B., & Meier, P. J. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1168-y · Cited by 1,019
Impact of OATP transporters on pharmacokinetics
Kalliokoski, A., & Niemi, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00430.x · Cited by 995
Koepsell, H., Lips, K., & Volk, C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9254-z · Cited by 988
The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver
Gerloff, T., Stieger, B., Hagenbuch, B., Madon, J., Landmann, L., Roth, J., Hofmann, A. F., & Meier, P. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.10046 · Cited by 939
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.-P., von Richter, O., Zundler, J., & Kroemer, H. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6663 · Cited by 917
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Klaassen, C. D., & Aleksunes, L. M. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002014 · Cited by 807
Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K., Meier, P. J., & Hagenbuch, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.21176 · Cited by 723
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Woodward, O. M., Köttgen, A., Coresh, J., Boerwinkle, E., Guggino, W. B., & Köttgen, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901249106 · Cited by 688
Cui, Y., König, J., Buchholz, U., Spring, H., Leier, I., & Keppler, D. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23190-4 · Cited by 676
Self-citationA Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)
Hsiang, B., Zhu, Y., Wang, Z., Wu, Y., Sasseville, V., Yang, W.-P., & Kirchgessner, T. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37161 · Cited by 641
Büchler, M., König, J., Brom, M., Kartenbeck, J., Spring, H., Horie, T., & Keppler, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15091 · Cited by 638
Self-citationCloning and Characterization of Two Human Polyspecific Organic Cation Transporters
GORBOULEV, V., ULZHEIMER, J. C., AKHOUNDOVA, A., ULZHEIMER-TEUBER, I., KARBACH, U., QUESTER, S., BAUMANN, C., LANG, F., BUSCH, A. E., & KOEPSELL, H. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.871 · Cited by 638
Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
Jonker, J. W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.20.1651 · Cited by 638
Niemi, M., Pasanen, M. K., & Neuvonen, P. J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002857 · Cited by 633
Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter
Sekine, T., Watanabe, N., Hosoyamada, M., Kanai, Y., & Endou, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18526 · Cited by 625
Lown, K. S., Bailey, D. G., Fontana, R. J., Janardan, S. K., Adair, C. H., Fortlage, L. A., Brown, M. B., Guo, W., & Watkins, P. B. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119439 · Cited by 624
König, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.1.g156 · Cited by 620
Self-citationHo, R. H., Tirona, R. G., Leake, B. F., Glaeser, H., Lee, W., Lemke, C. J., Wang, Y., & Kim, R. B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.034 · Cited by 611
Dresser, G. K., Bailey, D. G., Leake, B. F., Schwarz, U. I., Dawson, P. A., Freeman, D. J., & Kim, R. B. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.121152 · Cited by 606
Importance of P-glycoprotein at blood–tissue barriers
Fromm, M. F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.002 · Cited by 592
Self-citationJOHNE, A. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1053/cp.1999.v66.a101944 · Cited by 586
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
Dürr, D. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.112240 · Cited by 584
A human transporter protein that mediates the final excretion step for toxic organic cations
Otsuka, M., Matsumoto, T., Morimoto, R., Arioka, S., Omote, H., & Moriyama, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506483102 · Cited by 571
Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1
Abe, T., Kakyo, M., Tokui, T., Nakagomi, R., Nishio, T., Nakai, D., Nomura, H., Unno, M., Suzuki, M., Naitoh, T., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17159 · Cited by 543
The SLC22 drug transporter family
Koepsell, H., & Endou, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1089-9 · Cited by 525
Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide
König, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001448200 · Cited by 522
Self-citationHERMAN, G., STEVENS, C., VANDYCK, K., BERGMAN, A., YI, B., DESMET, M., SNYDER, K., HILLIARD, D., TANEN, M., & TANAKA, W. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.09.002 · Cited by 519
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
Cui, X., Schiff, R., Arpino, G., Osborne, C. K., & Lee, A. V. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.004 · Cited by 514
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Cha, S. H., Sekine, T., Fukushima, J.-I., Kanai, Y., Kobayashi, Y., Goya, T., & Endou, H. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12589-8 · Cited by 508
Transporters and drug therapy: Implications for drug disposition and disease
HO, R., & KIM, R. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.05.011 · Cited by 502
The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
Voora, D., Shah, S. H., Spasojevic, I., Ali, S., Reed, C. R., Salisbury, B. A., & Ginsburg, G. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.053 · Cited by 502
Kusuhara, H., Sekine, T., Utsunomiya-Tate, N., Tsuda, M., Kojima, R., Cha, S. H., Sugiyama, Y., Kanai, Y., & Endou, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13675 · Cited by 489
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.
Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C., Ruevekamp, M. C., Floot, B. G., & Schellens, J. H. M. (1999) · PubMed · Cited by 487
Kruijtzer, C. M. F., Beijnen, J. H., Rosing, H., ten Bokkel Huinink, W. W., Schot, M., Jewell, R. C., Paul, E. M., & Schellens, J. H. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.116 · Cited by 464
Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2
Ciarimboli, G., Ludwig, T., Lang, D., Pavenstädt, H., Koepsell, H., Piechota, H.-J., Haier, J., Jaehde, U., Zisowsky, J., & Schlatter, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61234-5 · Cited by 448
Ciarimboli, G., Deuster, D., Knief, A., Sperling, M., Holtkamp, M., Edemir, B., Pavenstädt, H., Lanvers-Kaminsky, C., am Zehnhoff-Dinnesen, A., Schinkel, A. H., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090610 · Cited by 444
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans
Hirano, M., Maeda, K., Shitara, Y., & Sugiyama, Y. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068056 · Cited by 443
Increased drug delivery to the brain by P-glycoprotein inhibition
Sadeque, A. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109156 · Cited by 426
Jonker, J. W., Merino, G., Musters, S., van Herwaarden, A. E., Bolscher, E., Wagenaar, E., Mesman, E., Dale, T. C., & Schinkel, A. H. (2005) · Nature Medicine · doi:10.1038/nm1186 · Cited by 423
Antiviral Drug-Induced Nephrotoxicity
Izzedine, H., Launay-Vacher, V., & Deray, G. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.02.010 · Cited by 423
Kobayashi, D., Nozawa, T., Imai, K., Nezu, J.-I., Tsuji, A., & Tamai, I. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051300 · Cited by 416
ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
Keskitalo, J. E., Zolk, O., Fromm, M. F., Kurkinen, K. J., Neuvonen, P. J., & Niemi, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.79 · Cited by 416
Self-citationGao, B., Hagenbuch, B., Kullak-Ublick, G. A., Benke, D., Aguzzi, A., & Meier, P. J. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39041-x · Cited by 412
Shitara, Y., Hirano, M., Sato, H., & Sugiyama, Y. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068536 · Cited by 407
Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans
Glaeser, H., Bailey, D. G., Dresser, G. K., Gregor, J. C., Schwarz, U. I., McGrath, J. S., Jolicoeur, E., Lee, W., Leake, B. F., Tirona, R. G., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100056 · Cited by 407
Fromm, M. F., Kim, R. B., Stein, C. M., Wilkinson, G. R., & Roden, D. M. (1999) · Circulation · doi:10.1161/01.cir.99.4.552 · Cited by 402
Self-citationP-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs
Fromm, M. F. (2000) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38069 · Cited by 399
Self-citationContribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
Filipski, K. K., Mathijssen, R. H., Mikkelsen, T. S., Schinkel, A. H., & Sparreboom, A. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.139 · Cited by 399
The apical conjugate efflux pump ABCC2 (MRP2)
Nies, A. T., & Keppler, D. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0109-y · Cited by 398
Nishimura, M., & Naito, S. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.452 · Cited by 388
Nies, A. T., Koepsell, H., Winter, S., Burk, O., Klein, K., Kerb, R., Zanger, U. M., Keppler, D., Schwab, M., & Schaeffeler, E. (2009) · Hepatology · doi:10.1002/hep.23103 · Cited by 387
Effect of grapefruit juice on digoxin pharmacokinetics in humans
Becquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M., Jaillon, P., & Funck‐Brentano, C. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(01)17221-8 · Cited by 387
van de Steeg, E., Stránecký, V., Hartmannová, H., Nosková, L., Hřebíček, M., Wagenaar, E., van Esch, A., de Waart, D. R., Oude Elferink, R. P. J., Kenworthy, K. E., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59526 · Cited by 384
Nies, A. T., Koepsell, H., Damme, K., & Schwab, M. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_3 · Cited by 375
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
Vavricka, S. R., Van Montfoort, J., Ha, H. R., Meier, P. J., & Fattinger, K. (2002) · Hepatology · doi:10.1053/jhep.2002.34133 · Cited by 373
Masuda, S., Terada, T., Yonezawa, A., Tanihara, Y., Kishimoto, K., Katsura, T., Ogawa, O., & Inui, K.-I. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030205 · Cited by 371
Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)
Lee, W., Glaeser, H., Smith, L. H., Roberts, R. L., Moeckel, G. W., Gervasini, G., Leake, B. F., & Kim, R. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411092200 · Cited by 365
Metformin is a Superior Substrate for Renal Organic Cation Transporter OCT2 rather than Hepatic OCT1
Kimura, N., Masuda, S., Tanihara, Y., Ueo, H., Okuda, M., Katsura, T., & Inui, K.-I. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.379 · Cited by 360
Pharmacogenomics of human OATP transporters
König, J., Seithel, A., Gradhand, U., & Fromm, M. F. (2006) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-006-0040-y · Cited by 357
Self-citationHO, E. S., LIN, D. C., MENDEL, D. B., & CIHLAR, T. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v113383 · Cited by 356
Cihlar, T., Lin, D. C., Pritchard, J. B., Fuller, M. D., Mendel, D. B., & Sweet, D. H. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23084-4 · Cited by 345
ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics
Suzuki, M., Suzuki, H., Sugimoto, Y., & Sugiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212399200 · Cited by 341
Lang, C., Meier, Y., Stieger, B., Beuers, U., Lang, T., Kerb, R., Kullak-Ublick, G. A., Meier, P. J., & Pauli-Magnus, C. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230418.28091.76 · Cited by 339
Byrne, J. A., Strautnieks, S. S., Mieli–Vergani, G., Higgins, C. F., Linton, K. J., & Thompson, R. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36591 · Cited by 337
EVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS
Shitara, Y., Sato, H., & Sugiyama, Y. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121444 · Cited by 336
SIMONSON, S. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.03.010 · Cited by 330
Lau, Y. Y., Huang, Y., Frassetto, L., & Benet, L. Z. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100038 · Cited by 327
Expression of members of the multidrug resistance protein family in human term placenta
St-Pierre, M. V., Serrano, M. A., Macias, R. I. R., Dubs, U., Hoechli, M., Lauper, U., Meier, P. J., & Marin, J. J. G. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1495 · Cited by 325
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
Prueksaritanont, T., Tang, C., Qiu, Y., Mu, L., Subramanian, R., & Lin, J. H. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.11.1280 · Cited by 325
Tirona, R. G., Leake, B. F., Wolkoff, A. W., & Kim, R. B. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043026 · Cited by 324
Renal Transporters in Drug Development
Morrissey, K. M., Stocker, S. L., Wittwer, M. B., Xu, L., & Giacomini, K. M. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140317 · Cited by 324
Mechanism of Active Renal Tubular Efflux of Tenofovir
Ray, A. S., Cihlar, T., Robinson, K. L., Tong, L., Vela, J. E., Fuller, M. D., Wieman, L. M., Eisenberg, E. J., & Rhodes, G. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00251-06 · Cited by 323
Multidrug Resistance Proteins (MRPs, ABCCs): Importance for Pathophysiology and Drug Therapy
Keppler, D. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_8 · Cited by 318
Koepsell, H., Schmitt, B. M., & Gorboulev, V. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0017-x · Cited by 316
DRUG-DRUG INTERACTION BETWEEN PITAVASTATIN AND VARIOUS DRUGS VIA OATP1B1
Hirano, M., Maeda, K., Shitara, Y., & Sugiyama, Y. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009290 · Cited by 302
Treiber, A., Schneiter, R., Häusler, S., & Stieger, B. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013615 · Cited by 299
Bronger, H., König, J., Kopplow, K., Steiner, H.-H., Ahmadi, R., Herold-Mende, C., Keppler, D., & Nies, A. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1271 · Cited by 295
Digoxin-Quinidine Interaction: Pharmacokinetic Evaluation
Hager, W. D., Fenster, P., Mayersohn, M., Perrier, D., Graves, P., Marcus, F. I., & Goldman, S. (1979) · New England Journal of Medicine · doi:10.1056/nejm197905313002202 · Cited by 291
Bailey, D. G., Dresser, G. K., Leake, B. F., & Kim, R. B. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100104 · Cited by 287
Sweet, D. H., Miller, D. S., Pritchard, J. B., Fujiwara, Y., Beier, D. R., & Nigam, S. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203803200 · Cited by 287
Westphal, K. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109797 · Cited by 285
Reduction of metformin renal tubular secretion by cimetidine in man.
Somogyi, A., Stockley, C., Keal, J., Rolan, P., & Bochner, F. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03090.x · Cited by 282
OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
Wang, Z.-J., Yin, O. Q. P., Tomlinson, B., & Chow, M. S. S. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328302cd41 · Cited by 281
The Effect of Rifampin Treatment on Intestinal Expression of Human MRP Transporters
Fromm, M. F., Kauffmann, H.-M., Fritz, P., Burk, O., Kroemer, H. K., Warzok, R. W., Eichelbaum, M., Siegmund, W., & Schrenk, D. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64794-3 · Cited by 277
Self-citationFenner, K., Troutman, M., Kempshall, S., Cook, J., Ware, J., Smith, D., & Lee, C. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.195 · Cited by 272
Takeda, M., Khamdang, S., Narikawa, S., Kimura, H., Hosoyamada, M., Cha, S. H., Sekine, T., & Endou, H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034330 · Cited by 269
Nies, A. T., Niemi, M., Burk, O., Winter, S., Zanger, U. M., Stieger, B., Schwab, M., & Schaeffeler, E. (2013) · Genome Medicine · doi:10.1186/gm405 · Cited by 265
Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males
Zhang, W., Yu, B.-N., He, Y.-J., Fan, L., Li, Q., Liu, Z.-Q., Wang, A., Liu, Y.-L., Tan, Z.-R., Fen-Jiang, et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.05.010 · Cited by 263
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects
Dresser, G. K., Schwarz, U. I., Wilkinson, G. R., & Kim, R. B. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.10 · Cited by 261
SCHAUB, T. P., KARTENBECK, J., KÖNIG, J., SPRING, H., DÖRSAM, J., STAEHLER, G., STÖRKEL, S., THON, W. F., & KEPPLER, D. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061159 · Cited by 256
Self-citationInvolvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin
Hirano, M., Maeda, K., Matsushima, S., Nozaki, Y., Kusuhara, H., & Sugiyama, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014019 · Cited by 256
Lopez-Nieto, C. E., You, G., Bush, K. T., Barros, E. J. G., Beier, D. R., & Nigam, S. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6471 · Cited by 252
P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies.
Wandel, C., Kim, R. B., Kajiji, S. M., Guengerich, P. F., Wilkinson, G. R., & Wood, A. J. J. (1999) · PubMed · Cited by 249
Characterization of uremic toxin transport by organic anion transporters in the kidney
Deguchi, T., Kusuhara, H., Takadate, A., Endou, H., Otagiri, M., & Sugiyama, Y. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00354.x · Cited by 244
Jacobson, T. A. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.07.080 · Cited by 243
Jacobsen, W., Kuhn, B., Soldner, A., Kirchner, G., Sewing, K.-F., Kollman, P. A., Benet, L. Z., & Christians, U. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15086-6 · Cited by 236
Effect of grapefruit juice on digoxin pharmacokinetics in humans.
Becquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M., Jaillon, P., & Funck‐Brentano, C. (2001) · PubMed · Cited by 234
Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles
Breedveld, P., Zelcer, N., Pluim, D., Sönmezer, O., Tibben, M. M., Beijnen, J. H., Schinkel, A. H., van Tellingen, O., Borst, P., & Schellens, J. H. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4062 · Cited by 233
Immunolocalization of Multispecific Organic Anion Transporters, OAT1, OAT2, and OAT3, in Rat Kidney
Kojima, R., Sekine, T., Kawachi, M., Cha, S. H., Suzuki, Y., & Endou, H. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134848 · Cited by 232
Fruit juice inhibition of uptake transport: a new type of food–drug interaction
Bailey, D. G. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03722.x · Cited by 222
Ohtsuki, S., Asaba, H., Takanaga, H., Deguchi, T., Hosoya, K., Otagiri, M., & Terasaki, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01108.x · Cited by 219
Kusuhara, H., Ito, S., Kumagai, Y., Jiang, M., Shiroshita, T., Moriyama, Y., Inoue, K., Yuasa, H., & Sugiyama, Y. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.36 · Cited by 217
Gupta, A., Zhang, Y., Unadkat, J. D., & Mao, Q. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.065342 · Cited by 216
Neuvonen, P. J., Backman, J. T., & Niemi, M. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847070-00003 · Cited by 216
GRUBE, M., KOCK, K., OSWALD, S., DRABER, K., MEISSNER, K., ECKEL, L., BOHM, M., FELIX, S., VOGELGESANG, S., & JEDLITSCHKY, G. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.09.010 · Cited by 215
Ito, S., Kusuhara, H., Yokochi, M., Toyoshima, J., Inoue, K., Yuasa, H., & Sugiyama, Y. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184986 · Cited by 211
Amphoux, A., Vialou, V., Drescher, E., Brüss, M., La Cour, C. M., Rochat, C., Millan, M. J., Giros, B., Bönisch, H., & Gautron, S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.005 · Cited by 211
Chen, C., Mireles, R. J., Campbell, S. D., Lin, J., Mills, J. B., Xu, J. J., & Smolarek, T. A. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002477 · Cited by 209
Seithel, A., Eberl, S., Singer, K., Auge, D., Heinkele, G., Wolf, N. B., Dörje, F., Fromm, M. F., & König, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.014407 · Cited by 207
Self-citationCyclosporine markedly raises the plasma concentrations of repaglinide
KAJOSAARI, L., NIEMI, M., NEUVONEN, M., LAITILA, J., NEUVONEN, P., & BACKMAN, J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.07.005 · Cited by 207
Cui, Y., König, J., & Keppler, D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12502-3 · Cited by 206
Self-citationThe Drug Transporter−Metabolism Alliance: Uncovering and Defining the Interplay
Benet, L. Z. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900253n · Cited by 205
P-glycoprotein: Tissue Distribution, Substrates, and Functional Consequences of Genetic Variations
Cascorbi, I. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_6 · Cited by 204
Interactions of Human Organic Anion Transporters with Diuretics
Hasannejad, H., Takeda, M., Taki, K., Shin, H. J., Babu, E., Jutabha, P., Khamdang, S., Aleboyeh, M., Onozato, M. L., Tojo, A., et al. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059139 · Cited by 200
Brunham, L. R., Lansberg, P. J., Zhang, L., Miao, F., Carter, C., Hovingh, G. K., Visscher, H., Jukema, J. W., Stalenhoef, A. F., Ross, C. J. D., et al. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.92 · Cited by 199
Elsby, R., Hilgendorf, C., & Fenner, K. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.163 · Cited by 198
Yonezawa, A., & Inui, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01394.x · Cited by 197
In Vitro and In Vivo Evidence of the Importance of Organic Anion Transporters (OATs) in Drug Therapy
Burckhardt, G., & Burckhardt, B. C. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_2 · Cited by 197
Human Hepatobiliary Transport of Organic Anions Analyzed by Quadruple-Transfected Cells
Kopplow, K., Letschert, K., König, J., Walter, B., & Keppler, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014605 · Cited by 197
Self-citationMinematsu, T., & Giacomini, K. M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0731 · Cited by 196
Tsuda, M., Terada, T., Ueba, M., Sato, T., Masuda, S., Katsura, T., & Inui, K.-I. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147918 · Cited by 194
Br�sen, K., Hansen, J. G., Nielsen, K. K., Sindrup, S. H., & Gram, L. F. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00316471 · Cited by 193
Ahlin, G., Karlsson, J., Pedersen, J. M., Gustavsson, L., Larsson, R., Matsson, P., Norinder, U., Bergström, C. A. S., & Artursson, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8003152 · Cited by 190
Matsushima, S., Maeda, K., Kondo, C., Hirano, M., Sasaki, M., Suzuki, H., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085589 · Cited by 190
Keskitalo, J. E., Pasanen, M. K., Neuvonen, P. J., & Niemi, M. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.85 · Cited by 189
Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance
Kyrklund, C. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00052-3 · Cited by 189
Benet, L., Cummins, C., & Wu, C. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489389 · Cited by 188
Kamisako, T., Leier, I., Cui, Y., König, J., Buchholz, U., Hummel-Eisenbeiss, J., & Keppler, D. (1999) · Hepatology · doi:10.1002/hep.510300220 · Cited by 184
Self-citationBile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, Pravastatin
Hirano, M., Maeda, K., Hayashi, H., Kusuhara, H., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084830 · Cited by 181
Uwai, Y., Ida, H., Tsuji, Y., Katsura, T., & Inui, K.-I. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9196-x · Cited by 180
Eagling, Profit, & Back (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00052.x · Cited by 179
Rodríguez‐Fragoso, L., Martínez‐Arismendi, J. L., Orozco‐Bustos, D., Reyes‐Esparza, J., Torres, E., & Burchiel, S. W. (2011) · Journal of Food Science · doi:10.1111/j.1750-3841.2011.02155.x · Cited by 179
Chu, X.-Y., Bleasby, K., Yabut, J., Cai, X., Chan, G. H., Hafey, M. J., Xu, S., Bergman, A. J., Braun, M. P., Dean, D. C., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116517 · Cited by 179
Funk, C. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00460-7 · Cited by 177
Pharmacogenetic determination of the effects of codeine and prediction of drug interactions.
Caraco, Y., Sheller, J., & Wood, A. J. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20766-2 · Cited by 176
Zhang, L., Schaner, M. E., & Giacomini, K. M. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37595-0 · Cited by 176
BindingDB (2013) · PubMed · doi:10.7270/q2571d9z · Cited by 172
Transporter-Mediated Drug–Drug Interactions
Müller, F., & Fromm, M. F. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.44 · Cited by 172
Self-citationTsuda, M., Terada, T., Mizuno, T., Katsura, T., Shimakura, J., & Inui, K.-I. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056242 · Cited by 172
Irinotecan-induced Diarrhea: Functional Significance of the Polymorphic ABCC2 Transporter Protein
de Jong, F. A., Scott-Horton, T. J., Kroetz, D. L., McLeod, H. L., Friberg, L. E., Mathijssen, R. H., Verweij, J., Marsh, S., & Sparreboom, A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100019 · Cited by 171
Tahara, H., Kusuhara, H., Endou, H., Koepsell, H., Imaoka, T., Fuse, E., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088104 · Cited by 171
Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers*1
DING, R. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.02.008 · Cited by 169
Huang, L., Wang, Y., & Grimm, S. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007534 · Cited by 169
Somogyi, A., McLean, A., & Heinzow, B. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf01037945 · Cited by 167
GIESSMANN, T., MAY, K., MODESS, C., WEGNER, D., HECKER, U., ZSCHIESCHE, M., DAZERT, P., GRUBE, M., SCHROEDER, E., & WARZOK, R. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.04.011 · Cited by 167
Lu, R., Chan, B. S., & Schuster, V. L. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.2.f295 · Cited by 166
Olbricht, C., Wanner, C., Eisenhauer, T., Kliem, V., Doll, R., Boddaert, M., O'Grady, P., Krekler, M., Mangold, B., & Christians, U. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90034-5 · Cited by 165
Contribution of OATP1B1 and OATP1B3 to the Disposition of Sorafenib and Sorafenib-Glucuronide
Zimmerman, E. I., Hu, S., Roberts, J. L., Gibson, A. A., Orwick, S. J., Li, L., Sparreboom, A., & Baker, S. D. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3306 · Cited by 164
Ieiri, I., Suwannakul, S., Maeda, K., Uchimaru, H., Hashimoto, K., Kimura, M., Fujino, H., Hirano, M., Kusuhara, H., Irie, S., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100190 · Cited by 164
Yonezawa, A., & Inui, K.-I. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.016 · Cited by 163
Zaher, H., Khan, A. A., Palandra, J., Brayman, T. G., Yu, L., & Ware, J. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050113v · Cited by 162
Reitman, M. L., Chu, X., Cai, X., Yabut, J. A., Venkatasubramanian, R., Zajic, S. C., Stone, J. A., Ding, Y., Witter, R., Gibson, C. R., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.271 · Cited by 159
Ohnishi, A., Matsuo, H., Yamada, S., Takanaga, H., Morimoto, S., Shoyama, Y., Ohtani, H., & Sawada, Y. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703433 · Cited by 158
P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humans
Drescher, S., Glaeser, H., Mürdter, T., Hitzl, M., Eichelbaum, M., & Fromm, M. F. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.27 · Cited by 158
Self-citationNozaki, Y., Kusuhara, H., Kondo, T., Iwaki, M., Shiroyanagi, Y., Nakayama, H., Horita, S., Nakazawa, H., Okano, T., & Sugiyama, Y. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121491 · Cited by 158
Ito, S., Kusuhara, H., Kuroiwa, Y., Wu, C., Moriyama, Y., Inoue, K., Kondo, T., Yuasa, H., Nakayama, H., Horita, S., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163642 · Cited by 154
Pharmacogenetics of drug‐induced liver injury†
Russmann, S., Jetter, A., & Kullak-Ublick, G. A. (2010) · Hepatology · doi:10.1002/hep.23720 · Cited by 149
Schaeffeler, E., Hellerbrand, C., Nies, A. T., Winter, S., Kruck, S., Hofmann, U., van der Kuip, H., Zanger, U. M., Koepsell, H., & Schwab, M. G. (2011) · Genome Medicine · doi:10.1186/gm298 · Cited by 149
Role of human organic anion transporter 4 in the transport of ochratoxin A
Babu, E., Takeda, M., Narikawa, S., Kobayashi, Y., Enomoto, A., Tojo, A., Ho, S., Sekine, T., Sakthisekaran, D., & Endou, H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00187-8 · Cited by 149
Rengelshausen, J., Göggelmann, C., Burhenne, J., Riedel, K., Ludwig, J., Weiß, J., Mikus, G., Walter‐Sack, I., & Haefeli, W. E. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01824.x · Cited by 148
Wang, X., Wolkoff, A. W., & Morris, M. E. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005926 · Cited by 148
van de Steeg, E., van Esch, A., Wagenaar, E., Kenworthy, K. E., & Schinkel, A. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2080 · Cited by 145
Noé, J., Kullak-Ublick, G. A., Jochum, W., Stieger, B., Kerb, R., Haberl, M., Müllhaupt, B., Meier, P. J., & Pauli‐Magnus, C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.020 · Cited by 143
Gurley, B. J., Swain, A., Williams, D. K., Barone, G. W., & Battu, S. K. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700081 · Cited by 143
Yamada, A., Maeda, K., Kamiyama, E., Sugiyama, D., Kondo, T., Shiroyanagi, Y., Nakazawa, H., Okano, T., Adachi, M., Schuetz, J. D., et al. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017459 · Cited by 143
Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol
Lilja, J. J., Backman, J. T., Laitila, J., Luurila, H., & Neuvonen, P. J. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.26 · Cited by 142
The History and Future of Probenecid
Robbins, N., Koch, S. E., Tranter, M., et al. (2011) · Cardiovascular Toxicology · doi:10.1007/s12012-011-9145-8 · Cited by 142
A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination
Hulot, J., Villard, E., Maguy, A., Morel, V., Mir, L. M., Tostivint, I. N., Faltaos, D. W., Fernandez, C., Hatem, S. N., Deray, G., et al. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200505000-00002 · Cited by 141
Hasegawa, M., Kusuhara, H., Sugiyama, D., Ito, K., Ueda, S., Endou, H., & Sugiyama, Y. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.746 · Cited by 141
Yamazaki, M., Akiyama, S., Ni'inuma, K., Nishigaki, R., & Sugiyama, Y. (1997) · PubMed · doi:10.7270/q2cr5vmx · Cited by 140
Mandery, K., Bujok, K., Schmidt, I., Keiser, M., Siegmund, W., Balk, B., König, J., Fromm, M. F., & Glaeser, H. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.008 · Cited by 137
Self-citationUptake Transporters of the Human OATP Family
König, J. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-14541-4_1 · Cited by 136
Self-citationLacy, S. A., Hitchcock, M. J. M., Lee, W. A., Tellier, P., & Cundy, K. C. (1998) · Toxicological Sciences · doi:10.1093/toxsci/44.2.97 · Cited by 136
Amundsen, R., Christensen, H., Zabihyan, B., & Åsberg, A. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032268 · Cited by 135
Overexpression of OATP1B3 Confers Apoptotic Resistance in Colon Cancer
Lee, W., Belkhiri, A., Lockhart, A. C., Merchant, N. B., Glaeser, H., Harris, E. I., Washington, M. K., Brunt, E. M., Zaika, A., Kim, R. B., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1984 · Cited by 134
Takanaga, H., Ohnishi, A., Yamada, S., et al. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39224-9 · Cited by 133
Neuvonen, P. J. (2010) · PubMed · Cited by 133
Schwarz, U. I., Hanso, H., Oertel, R., Miehlke, S., Kuhlisch, E., Glaeser, H., Hitzl, M., Dresser, G. K., Kim, R. B., & Kirch, W. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100191 · Cited by 132
Muzi, M., Mankoff, D. A., Link, J. M., Shoner, S., Collier, A. C., Sasongko, L., & Unadkat, J. D. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.059162 · Cited by 132
Terada, T., Masuda, S., Asaka, J., Tsuda, M., Katsura, T., & Inui, K. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9016-3 · Cited by 130
Gießmann, T., Modeß, C., Hecker, U., Zschiesche, M., Dazert, P., Kunert‐Keil, C., Warzok, R., Engel, G., Weitschies, W., Cascorbi, I., et al. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.10.004 · Cited by 130
Organic anion transporters and their implications in pharmacotherapy
Emami Riedmaier, A., Nies, A. T., Schaeffeler, E., & Schwab, M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004614 · Cited by 128
Gupta, A., Dai, Y., Vethanayagam, R. R., Hébert, M. F., Thummel, K. E., Unadkat, J. D., Ross, D. D., & Mao, Q. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0173-6 · Cited by 126
Organic Anion Transporter 2 (SLC22A7) Is a Facilitative Transporter of cGMP
Cropp, C. D., Komori, T., Shima, J. E., Urban, T. J., Yee, S. W., More, S. S., & Giacomini, K. M. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043117 · Cited by 126
Interaction of Oral Antidiabetic Drugs With Hepatic Uptake Transporters
Bachmakov, I., Glaeser, H., Fromm, M. F., & König, J. (2008) · Diabetes · doi:10.2337/db07-1515 · Cited by 125
Self-citationNies, A. T., Herrmann, E., Brom, M., & KEPPLER, D. O. R. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0219-x · Cited by 124
Yoshida, K. J., Maeda, K., & Sugiyama, Y. (2012) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140309 · Cited by 123
Nies, A. T., Schwab, M. G., & KEPPLER, D. O. R. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.5.545 · Cited by 122
Interaction of human organic anion transporters with various cephalosporin antibiotics
Takeda, M., Babu, E., Narikawa, S., & Endou, H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01306-7 · Cited by 121
Role of P-Glycoprotein Inhibition for Drug Interactions
Eberl, S., Renner, B., Neubert, A. C., Reisig, M., Bachmakov, I., König, J., Dörje, F., Mürdter, T. E., Ackermann, A., Dormann, H., et al. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746120-00004 · Cited by 120
Self-citationde Castro, W. V., Mertens‐Talcott, S. U., Rubner, A., et al. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0516944 · Cited by 116
Cited by
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.002 · Cited by 1,035
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L., & Li, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.010 · Cited by 729
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
Fattorusso, A., Matricardi, S., Mencaroni, E., Dell'Isola, G. B., Di Cara, G., Striano, P., & Verrotti, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.674483 · Cited by 269
Drozdzik, M., Gröer, C., Penski, J., Lapczuk, J., Ostrowski, M., Lai, Y., Prasad, B., Unadkat, J. D., Siegmund, W., & Oswald, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500330y · Cited by 258
Metadata
- Authors
- König, J., Müller, F., & Fromm, M. F.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 65
- Issue
- 3
- Pages
- 944-966
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2098118571
- Cited by
- 575
- References
- 289
- FWCI
- 26.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.